Today: 26 June 2026
Browse Category

CSE:NOVO-B.CO 20 November 2025 - 2 February 2026

Billion-Dollar Brawl: Novo Nordisk and Pfizer Clash in High-Stakes Obesity Drug Takeover

Novo Nordisk Stock Today (November 20, 2025): Wegovy Price Cuts, Alzheimer’s ‘Lottery Ticket’ Trials and Denmark GDP Put NVO Back in the Spotlight

Novo Nordisk’s U.S. ADR traded near $49 Thursday, steady after a 3% rebound, while Copenhagen shares rose about 2–2.5% to DKK 318–319. The company faces slowing GLP-1 demand, price cuts, and high-profile Alzheimer’s trials, with results expected December 3. Shares remain down over 10% in three months and nearly 46% year-to-date after guidance cuts.
20 November 2025
···

Stock Market Today

  • SpaceX Employees Profit from IPO While Blue Origin Staff Miss Out
    June 26, 2026, 7:51 AM EDT. SpaceX employees have reaped significant financial rewards following the company's IPO, highlighting a stark contrast with Blue Origin workers who have not benefited similarly. The SpaceX public offering has allowed employees to convert stock options into tangible wealth, a key element in attracting and retaining talent in the competitive aerospace industry. Meanwhile, Blue Origin's private status has limited employee access to such liquidity events despite both companies operating in the same sector. This disparity underscores broader trends in equity compensation and liquidity opportunities within private versus public firms in the high-tech space market.

Latest News

Triller jumps, SpaceX stake now values above its market cap

Triller jumps, SpaceX stake now values above its market cap

26 June 2026
Triller shares soared 95% premarket after revealing a $411.3 million SpaceX-linked purchase—nearly seven times its equity value at Thursday’s close—though the deal, still pending escrow and conditions, highlights a massive size mismatch and comes as Triller faces a $346 million working-capital deficit and warns its cash is insufficient for the next year.
Intel (NASDAQ: INTC) Gets an Apple Premium, Math Shows Little Room Left

Intel’s 2026 gains meet pressure with chip shares down premarket

26 June 2026
Intel tumbled over 3% premarket as chip stocks slid, with shares now trading nearly 30% above Wall Street’s average 12-month target despite a $3.7 billion quarterly loss and warnings that next-gen chip work could pause without more demand; investors await Q2 results July 23, with EPS seen at 21 cents.
Go toTop